Does the Bethesda Category Predict Aggressive Features in Differentiated Thyroid Cancer?

Archives of endocrinology and metabolism - Brazil
doi 10.20945/2359-3997000000098
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Archives of Endocrinology and Metabolism

Related search

Thyroid Cancer Detection Rate and Associated Risk Factors in Patients With Thyroid Nodules Classified as Bethesda Category III

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Surgeon-Performed Ultrasound Can Predict Differentiated Thyroid Cancer in Patients With Solitary Thyroid Nodules

Annals of Surgical Oncology
OncologySurgery
2010English

Differentiated Thyroid Cancer

Archives of Surgery
1998English

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology

PLoS ONE
Multidisciplinary
2016English

Clinicopathological Features Predict Outcomes in Patients With Radioiodine‐Refractory Differentiated Thyroid Cancer Treated With Sorafenib: A Real‐World Study

Oncologist
Cancer ResearchMedicineOncology
2020English

Serum Thyroglobulin in Differentiated Thyroid Cancer.

BMJ
1979English

Management of Differentiated Thyroid Cancer in Pregnancy

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2011English

Differentiated Thyroid Cancer in Patients With Prolactinoma

Turkish Journal of Medical Sciences
Medicine
2016English

Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer

New England Journal of Medicine
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy